Introduction
Over the last few decades the increasing pathogenicity and capacity to produce β-lactamase enzyme has evolved Moraxella catarrhalis (M. catarrhalis) from a benign commensal to a genuine pathogen [1, 2] . Currently, it is considered as one of the common cause of upper and lower respiratory tract infections. Though rarely reported, it can also cause severe infections including pneumonia, endocarditis, septicaemia and meningitis etc [1] [2] [3] [4] . M. catarrhalis also contributes in mixed respiratory tract infections with other pathogens such as Streptococcus pneumoniae ( S. pneumoniae) and/or Haemophilus influenzae (H. influenzae). In such cases, β-lactamase produced by this organism may render ampicillin ineffective against susceptible S. pneumoniae and H.
influenzae [5] .
Sweden was the first country to report the presence of β-lactamase in M. catarrhalis in 1977 [6] . Since then β-lactamase production has been reported from various countries with increasing frequency (even above 90%) [7] [8] [9] . Though it remains rare, reports of increasing resistance to other oral antibiotics useful to treat community acquired respiratory tract infections (CARTI) are also documented in M. catarrhalis [10, 11] .
Information regarding frequency of β-lactamase production in M. catarrhalis is limited from Pakistan. A study from Pakistan reported 93.5% ampicillin susceptibility in M. catarrhalis but authors did not report β-lactamase activity in those isolates [12] . Another study reported 68.7% β-lactamase production in M. catarrhalis. However this study had the limitations of small sample size and use of less sensitive filter paper acidometric test for β-lactamase detection [13] . The local antimicrobial susceptibility data of other oral antibiotics used for CARTI against M. catarrhalis is also missing. Surveillance to monitor shifting trends in resistance is vital as it ultimately influences the selection of antimicrobial agents 
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available for use against a particular organism. Therefore, this study aimed to assess the frequency of β-lactamase production in M. catarrhalis and also drug resistance against ampicillin, erythromycin, ciprofloxacin and tetracycline, so as to guide empirical therapy in CARTI.
Material and methods
This cross sectional study was conducted from January 2010 to December 2010 in the clinical microbiology laboratory of Aga Khan University Hospital (AKUH). The AKUH laboratory has an extensive network of more than 200 collection units throughout Pakistan. Through this it caters a vast outpatient population across the country.
Respiratory specimens
Clinical respiratory specimens (sputum, tracheal aspirate, bronchoalveolar lavage, middle ear fluid, nasopharyngeal swab/aspirate and sinus aspirate) from community that were received in AKUH laboratory for culture and sensitivities during study period were included.
Isolation of M. catarrhalis
The identification of the M. catarrhalis was confirmed by colony morphology, Gram stain appearance and conventional biochemical tests such as positive oxidase, catalase, and DNAase test. Clinical isolates were saved in glycerol-phosphate buffer at -80 °C . Duplicate samples from same patient were excluded. Demographic data including gender and age and seasonal distribution were also noted.
Antimicrobial susceptibility testing
Ampicillin, erythromycin, ciprofloxacin, and tetracycline powder were obtained from Sigma-Aldrich, UK. Minimum inhibitory concentrations (MICs) of the antimicrobials were performed according to agar dilution method recommended by British Society for Chemotherapy (BSAC) [14] . Agar plates were prepared with the antimicrobials to be tested incorporated in the media supplemented with 5% defibrinated blood in double dilution series. Bacterial suspension 10 4 CFU/spot was prepared and applied by the multipoint inoculator. For testing ampicillin, inoculum of 10 6 CFU was used. Plates were incubated at 37 °C aerobically for 18 h. MIC breakpoints provided by the BSAC [15] were used for interpretation and isolates were categorized as being sensitive (S), intermediately susceptible (I), or resistant (R). 
Data management and statistical analysis
Data was entered and analysed by the statistical software SPSS version 19 .0. Frequencies with percentages for age and seasonal distribution, β-lactamase production and resistance for each drug were computed.
Ethical approval
This study was approved by the Ethics Review Committee of the Aga Khan University, Pakistan.
Results
A total of 4 440 respiratory specimens were received during study period. Out of these, 30% ( Majority of isolates (50.5%, 49) were grown in the winter months (November-February) with the peak incidence in the month of January (Figure 1 ). β-Lactamase production was detected in 84.5% (81) of isolates, which correlated well with the high ampicillin MIC among them. Ninety-seven percent of isolates were found susceptible to erythromycin with MIC 90 of 0.12 mg/L and ninety-six percent susceptible to tetracycline with MIC 90 of 1 mg/L. All isolates were susceptible to ciprofloxacin. The MIC distribution for the four antibiotics tested is given in Table 2 . 
Discussion
This study suggests that empirical use of ampicillin/ amoxicillin in CARTI would miss β-lactamase producing M. catarrhalis strains and may lead to treatment failure. It may also hamper the treatment of certain concomitant organisms, such as penicillin susceptible S. pneumoniae and H. influenzae in cases of co-infection [1, 5] .
This study demonstrates that frequency of β-lactamase production among M. catarrhalis is entirely consistent with what reported globally [7] [8] [9] . Previous study from Pakistan reported 68.7% β-lactamase production. However, in that study they used less sensitive acidometric test for enzyme detection [13] . Increasing frequency of enzyme production was reported from the neighbouring country India. Larson et al. reported enzyme production in 68% isolates in 1999 and Anita et al. demonstrated 86% of isolates with enzyme activity in 2011 [16] [17] .
In this study, high ampicillin MIC correlates well with high β-lactamase production. Previously published work from Pakistan reported 93.5% susceptibility to this drug. However, that study had major limitation that authors did not test the β-lactamase production in their isolates by the standard method [12] .
Another important and promising finding of our study is that, resistance to other commonly used oral antibiotics in CARTI such as tetracycline and erythromycin remained low. Our finding regarding the tetracycline resistance is comparable to those obtained from most Asia pacific regions (3.2%) except Taiwan where it is around 19% [9, 18] . Similarly macrolide resistance is comparable to China 5.8%, however it is much lower than that reported previously from Pakistan (25%) [7, 12] .
Although ciprofloxacin is an accessible over the counter drug in Pakistan and easily available with or without a prescription, fortunately none of the isolate was found to be ciprofloxacin resistant. This finding is consistent with other reports published globally [7] [8] [9] . Though Tabussum et al. from Karachi reported 7% and a study from India reported 20% ciprofloxacin resistance [12, 19] .
Globally, recovery of majority of the isolates from respiratory samples from male patients was also observed in this study [20] . We also found that M. catarrhalis infections are more frequent among older age group. Similar finding was reported from India and Nepal [20, 21] . The predilection of CARTI in the older age group has been studied and several reasons have been proposed including age related changes in systemic immunity, respiratory tract mucosal changes due to smoking and several other co-morbidities [1, 2, 22] .
Majority of isolates were recovered in winter season, which is similar to finding of others [20] [21] [22] . A viral co-infection has been anticipated as the mechanism for the seasonal variation, it causes weakening of local immunity thereby promoting infection by these pathogens [22] .
This study is limited by its inability to perform molecular detection of BRO 1 and 2 for identification of β-lactamase enzymes. But it may be anticipated that majority were BRO 1 β-lactamase enzyme as they had high MICs for ampicillin [23] .
In summary, result of this study supports the recommendation of BSAC in 2011 that clinical laboratories are no more required to check the susceptibility of ampicillin against M. catarrhalis and should report them resistant [24] . Therefore appropriate alternative antibiotic should be S231 selected empirically in regard of treating CARTI. Finally we emphasize the judicious use of antibiotics in this region and continued surveillance to detect emerging resistance.
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